MARKET
IPO

WCGC

WCG Clinical, Inc.
WCGC
NASDAQ
Upcoming IPOs
Expected Listing Date: - -
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-58.62~-51.72
-
-
-
Biotechnology & Medical Research
2021-07-01
Public Filing
View Prospectus
Pending
Offering
Price Range: 15.00~17.00
Shares to be Issued: 45.00M
Pending
Offering End Date
Offering Price: Pending
Post IPO Outstanding: Pending
Listed
No Data
About WCGC
WCG Clinical, Inc. is a provider of clinical trial solutions, focused on providing solutions that are designed to improve clinical research. The Company's solutions help biopharmaceutical companies, contract research organizations, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the standards of human protection. It is organized into two segments: Ethical Review (ER) segment and Clinical Trial Solutions segment. The ER segment provides technology-enabled services that ensure clinical trials respect the rights and protect the welfare of patient participants. ER segment also provides a hosted software application to its clients. Clinical Trial Solutions (CTS) segment provides an integrated suite of over 40 technology-enabled solutions that support the conduct of effective clinical trials, including study planning and site optimization, patient engagement, and scientific and regulatory review.

Webull offers WCG Clinical, Inc. stock information, including NASDAQ: WCGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WCGC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WCGC stock methods without spending real money on the virtual paper trading platform.